| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.12 | 0.03 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.088 | 0.05 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.068 | 0.1 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | -0.064 | 0.1 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.06 | 0.2 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | -0.066 | 0.2 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.068 | 0.2 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | -0.064 | 0.2 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | -0.052 | 0.2 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | -0.038 | 0.4 |